Thought leadership and innovation for the Pharmaceutical Industry
Dr Avi Spira: Janssen's use of new technology to intercept lung cancer
Dr Avi Spira, Global Head of Johnson & Johnson's Lung Cancer Initiative on their use of ML, Robotics and Molecular Technology to intercept lung cancer.